Subsequent investigations that established that antagonistic interactions exist between A2AR and dopamine D2 receptors spurred the search for A2AR-specific antagonists [47] such as KW-6002, a compound that showed therapeutic value in MPTP-treated marmosets an animal model of PD [48]. This evidence concerns the gene DRD2 and Parkinson disease.